ES2847599T3 - Dispositivo para dispensar un fármaco - Google Patents
Dispositivo para dispensar un fármaco Download PDFInfo
- Publication number
- ES2847599T3 ES2847599T3 ES15779121T ES15779121T ES2847599T3 ES 2847599 T3 ES2847599 T3 ES 2847599T3 ES 15779121 T ES15779121 T ES 15779121T ES 15779121 T ES15779121 T ES 15779121T ES 2847599 T3 ES2847599 T3 ES 2847599T3
- Authority
- ES
- Spain
- Prior art keywords
- drug
- spreader
- pump
- receptacle
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 605
- 229940079593 drug Drugs 0.000 title claims abstract description 604
- 230000000007 visual effect Effects 0.000 claims abstract description 51
- 230000007480 spreading Effects 0.000 claims abstract description 11
- 238000003892 spreading Methods 0.000 claims abstract description 11
- 238000011200 topical administration Methods 0.000 claims description 13
- 239000006071 cream Substances 0.000 claims description 5
- 239000000499 gel Substances 0.000 claims description 5
- 239000006210 lotion Substances 0.000 claims description 5
- 210000001061 forehead Anatomy 0.000 claims description 3
- 210000004392 genitalia Anatomy 0.000 claims description 3
- 239000006193 liquid solution Substances 0.000 claims description 3
- 239000006194 liquid suspension Substances 0.000 claims description 3
- 239000000243 solution Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 description 40
- UOWOLENSDISMPG-FFUVTKDNSA-M [(3S)-1,1-dimethylpyrrolidin-1-ium-3-yl] (2R)-2-cyclopentyl-2-hydroxy-2-phenylacetate 4-methylbenzenesulfonate hydrate Chemical compound O.Cc1ccc(cc1)S([O-])(=O)=O.C[N+]1(C)CC[C@@H](C1)OC(=O)[C@@](O)(C1CCCC1)c1ccccc1 UOWOLENSDISMPG-FFUVTKDNSA-M 0.000 description 22
- 230000002093 peripheral effect Effects 0.000 description 16
- 230000007246 mechanism Effects 0.000 description 14
- 239000012528 membrane Substances 0.000 description 12
- 239000004676 acrylonitrile butadiene styrene Substances 0.000 description 10
- 230000000699 topical effect Effects 0.000 description 10
- XECAHXYUAAWDEL-UHFFFAOYSA-N acrylonitrile butadiene styrene Chemical compound C=CC=C.C=CC#N.C=CC1=CC=CC=C1 XECAHXYUAAWDEL-UHFFFAOYSA-N 0.000 description 9
- 229920000122 acrylonitrile butadiene styrene Polymers 0.000 description 9
- 230000008859 change Effects 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 230000000994 depressogenic effect Effects 0.000 description 8
- 238000013461 design Methods 0.000 description 8
- 230000004044 response Effects 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 229920002725 thermoplastic elastomer Polymers 0.000 description 7
- 238000003466 welding Methods 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 6
- 230000001070 adhesive effect Effects 0.000 description 6
- 239000013013 elastic material Substances 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 238000012377 drug delivery Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 4
- 208000002474 Tinea Diseases 0.000 description 4
- OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 4
- 229960002227 clindamycin Drugs 0.000 description 4
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 4
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 description 4
- 230000036961 partial effect Effects 0.000 description 4
- 229940036234 tazorac Drugs 0.000 description 4
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 4
- VPNYRYCIDCJBOM-UHFFFAOYSA-M Glycopyrronium bromide Chemical compound [Br-].C1[N+](C)(C)CCC1OC(=O)C(O)(C=1C=CC=CC=1)C1CCCC1 VPNYRYCIDCJBOM-UHFFFAOYSA-M 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 230000002745 absorbent Effects 0.000 description 3
- 239000002250 absorbent Substances 0.000 description 3
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 229960002462 glycopyrronium bromide Drugs 0.000 description 3
- 230000037315 hyperhidrosis Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 penederm Chemical compound 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 229960003981 proparacaine Drugs 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 201000010153 skin papilloma Diseases 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 229940126702 topical medication Drugs 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229960001727 tretinoin Drugs 0.000 description 3
- 239000011800 void material Substances 0.000 description 3
- AZSNMRSAGSSBNP-UHFFFAOYSA-N 22,23-dihydroavermectin B1a Natural products C1CC(C)C(C(C)CC)OC21OC(CC=C(C)C(OC1OC(C)C(OC3OC(C)C(O)C(OC)C3)C(OC)C1)C(C)C=CC=C1C3(C(C(=O)O4)C=C(C)C(O)C3OC1)O)CC4C2 AZSNMRSAGSSBNP-UHFFFAOYSA-N 0.000 description 2
- SPBDXSGPUHCETR-JFUDTMANSA-N 8883yp2r6d Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](OC)C[C@H](O[C@@H]2C(=C/C[C@@H]3C[C@@H](C[C@@]4(O[C@@H]([C@@H](C)CC4)C(C)C)O3)OC(=O)[C@@H]3C=C(C)[C@@H](O)[C@H]4OC\C([C@@]34O)=C/C=C/[C@@H]2C)/C)O[C@H]1C.C1C[C@H](C)[C@@H]([C@@H](C)CC)O[C@@]21O[C@H](C\C=C(C)\[C@@H](O[C@@H]1O[C@@H](C)[C@H](O[C@@H]3O[C@@H](C)[C@H](O)[C@@H](OC)C3)[C@@H](OC)C1)[C@@H](C)\C=C\C=C/1[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\1)O)C[C@H]4C2 SPBDXSGPUHCETR-JFUDTMANSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 2
- 108010081589 Becaplermin Proteins 0.000 description 2
- 239000004342 Benzoyl peroxide Substances 0.000 description 2
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007163 Dermatomycoses Diseases 0.000 description 2
- 208000008960 Diabetic foot Diseases 0.000 description 2
- VDJHFHXMUKFKET-UHFFFAOYSA-N Ingenol mebutate Natural products CC1CC2C(C)(C)C2C2C=C(CO)C(O)C3(O)C(OC(=O)C(C)=CC)C(C)=CC31C2=O VDJHFHXMUKFKET-UHFFFAOYSA-N 0.000 description 2
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 2
- YTAOBBFIOAEMLL-REQDGWNSSA-N Luliconazole Chemical compound ClC1=CC(Cl)=CC=C1[C@H](CS\1)SC/1=C(\C#N)N1C=NC=C1 YTAOBBFIOAEMLL-REQDGWNSSA-N 0.000 description 2
- ZFMITUMMTDLWHR-UHFFFAOYSA-N Minoxidil Chemical compound NC1=[N+]([O-])C(N)=CC(N2CCCCC2)=N1 ZFMITUMMTDLWHR-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000010195 Onychomycosis Diseases 0.000 description 2
- 241001674048 Phthiraptera Species 0.000 description 2
- 102100040990 Platelet-derived growth factor subunit B Human genes 0.000 description 2
- 229920001363 Polidocanol Polymers 0.000 description 2
- KCLANYCVBBTKTO-UHFFFAOYSA-N Proparacaine Chemical compound CCCOC1=CC=C(C(=O)OCCN(CC)CC)C=C1N KCLANYCVBBTKTO-UHFFFAOYSA-N 0.000 description 2
- 201000004681 Psoriasis Diseases 0.000 description 2
- 241001303601 Rosacea Species 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 206010040954 Skin wrinkling Diseases 0.000 description 2
- QJJXYPPXXYFBGM-LFZNUXCKSA-N Tacrolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1\C=C(/C)[C@@H]1[C@H](C)[C@@H](O)CC(=O)[C@H](CC=C)/C=C(C)/C[C@H](C)C[C@H](OC)[C@H]([C@H](C[C@H]2C)OC)O[C@@]2(O)C(=O)C(=O)N2CCCC[C@H]2C(=O)O1 QJJXYPPXXYFBGM-LFZNUXCKSA-N 0.000 description 2
- 208000007712 Tinea Versicolor Diseases 0.000 description 2
- 201000010618 Tinea cruris Diseases 0.000 description 2
- 206010056131 Tinea versicolour Diseases 0.000 description 2
- 241000893966 Trichophyton verrucosum Species 0.000 description 2
- 206010067409 Trichophytosis Diseases 0.000 description 2
- 206010046996 Varicose vein Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 208000009621 actinic keratosis Diseases 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229960002916 adapalene Drugs 0.000 description 2
- LZCDAPDGXCYOEH-UHFFFAOYSA-N adapalene Chemical compound C1=C(C(O)=O)C=CC2=CC(C3=CC=C(C(=C3)C34CC5CC(CC(C5)C3)C4)OC)=CC=C21 LZCDAPDGXCYOEH-UHFFFAOYSA-N 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229960002459 alefacept Drugs 0.000 description 2
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 230000001166 anti-perspirative effect Effects 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- HYNPZTKLUNHGPM-KKERQHFVSA-N becaplermin Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N3CCC[C@H]3C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@@H]4CCCN4C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]5CCCN5C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H]6CCCN6C(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]7CCCN7C(=O)[C@H](Cc8c[nH]c9c8cccc9)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CCSC)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)N HYNPZTKLUNHGPM-KKERQHFVSA-N 0.000 description 2
- 229960004787 becaplermin Drugs 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229960005274 benzocaine Drugs 0.000 description 2
- 229960003328 benzoyl peroxide Drugs 0.000 description 2
- 235000019400 benzoyl peroxide Nutrition 0.000 description 2
- 229960002537 betamethasone Drugs 0.000 description 2
- UREBDLICKHMUKA-DVTGEIKXSA-N betamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-DVTGEIKXSA-N 0.000 description 2
- 229960000400 butamben Drugs 0.000 description 2
- IUWVALYLNVXWKX-UHFFFAOYSA-N butamben Chemical compound CCCCOC(=O)C1=CC=C(N)C=C1 IUWVALYLNVXWKX-UHFFFAOYSA-N 0.000 description 2
- 229960002962 butenafine Drugs 0.000 description 2
- ABJKWBDEJIDSJZ-UHFFFAOYSA-N butenafine Chemical compound C=1C=CC2=CC=CC=C2C=1CN(C)CC1=CC=C(C(C)(C)C)C=C1 ABJKWBDEJIDSJZ-UHFFFAOYSA-N 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940069078 citric acid / sodium citrate Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 201000003929 dermatomycosis Diseases 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 229960003937 efinaconazole Drugs 0.000 description 2
- NFEZZTICAUWDHU-RDTXWAMCSA-N efinaconazole Chemical compound N1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)CCC(=C)CC1 NFEZZTICAUWDHU-RDTXWAMCSA-N 0.000 description 2
- YJGVMLPVUAXIQN-UHFFFAOYSA-N epipodophyllotoxin Natural products COC1=C(OC)C(OC)=CC(C2C3=CC=4OCOC=4C=C3C(O)C3C2C(OC3)=O)=C1 YJGVMLPVUAXIQN-UHFFFAOYSA-N 0.000 description 2
- 229960003276 erythromycin Drugs 0.000 description 2
- 230000003676 hair loss Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- VDJHFHXMUKFKET-WDUFCVPESA-N ingenol mebutate Chemical compound C[C@@H]1C[C@H]2C(C)(C)[C@H]2[C@@H]2C=C(CO)[C@@H](O)[C@]3(O)[C@@H](OC(=O)C(\C)=C/C)C(C)=C[C@]31C2=O VDJHFHXMUKFKET-WDUFCVPESA-N 0.000 description 2
- 229960002993 ingenol mebutate Drugs 0.000 description 2
- 229960002418 ivermectin Drugs 0.000 description 2
- 229960004194 lidocaine Drugs 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 229960000570 luliconazole Drugs 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- HAWPXGHAZFHHAD-UHFFFAOYSA-N mechlorethamine Chemical compound ClCCN(C)CCCl HAWPXGHAZFHHAD-UHFFFAOYSA-N 0.000 description 2
- 229960004961 mechlorethamine Drugs 0.000 description 2
- 229960003632 minoxidil Drugs 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229960003502 oxybuprocaine Drugs 0.000 description 2
- CMHHMUWAYWTMGS-UHFFFAOYSA-N oxybuprocaine Chemical compound CCCCOC1=CC(C(=O)OCCN(CC)CC)=CC=C1N CMHHMUWAYWTMGS-UHFFFAOYSA-N 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 201000000508 pityriasis versicolor Diseases 0.000 description 2
- 229940068585 podofilox Drugs 0.000 description 2
- YJGVMLPVUAXIQN-XVVDYKMHSA-N podophyllotoxin Chemical compound COC1=C(OC)C(OC)=CC([C@@H]2C3=CC=4OCOC=4C=C3[C@H](O)[C@@H]3[C@@H]2C(OC3)=O)=C1 YJGVMLPVUAXIQN-XVVDYKMHSA-N 0.000 description 2
- ONJQDTZCDSESIW-UHFFFAOYSA-N polidocanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO ONJQDTZCDSESIW-UHFFFAOYSA-N 0.000 description 2
- 229960002226 polidocanol Drugs 0.000 description 2
- 229960001896 pramocaine Drugs 0.000 description 2
- DQKXQSGTHWVTAD-UHFFFAOYSA-N pramocaine Chemical compound C1=CC(OCCCC)=CC=C1OCCCN1CCOCC1 DQKXQSGTHWVTAD-UHFFFAOYSA-N 0.000 description 2
- 229940126532 prescription medicine Drugs 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 201000004700 rosacea Diseases 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- IHCDKJZZFOUARO-UHFFFAOYSA-M sulfacetamide sodium Chemical compound O.[Na+].CC(=O)[N-]S(=O)(=O)C1=CC=C(N)C=C1 IHCDKJZZFOUARO-UHFFFAOYSA-M 0.000 description 2
- 230000003746 surface roughness Effects 0.000 description 2
- 229960001967 tacrolimus Drugs 0.000 description 2
- QJJXYPPXXYFBGM-SHYZHZOCSA-N tacrolimus Natural products CO[C@H]1C[C@H](CC[C@@H]1O)C=C(C)[C@H]2OC(=O)[C@H]3CCCCN3C(=O)C(=O)[C@@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@@H](C[C@H](C)CC(=C[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)C)OC QJJXYPPXXYFBGM-SHYZHZOCSA-N 0.000 description 2
- 229960002722 terbinafine Drugs 0.000 description 2
- 229960000699 terbinafine hydrochloride Drugs 0.000 description 2
- FPZLLRFZJZRHSY-HJYUBDRYSA-N tigecycline Chemical compound C([C@H]1C2)C3=C(N(C)C)C=C(NC(=O)CNC(C)(C)C)C(O)=C3C(=O)C1=C(O)[C@@]1(O)[C@@H]2[C@H](N(C)C)C(O)=C(C(N)=O)C1=O FPZLLRFZJZRHSY-HJYUBDRYSA-N 0.000 description 2
- 229960004089 tigecycline Drugs 0.000 description 2
- 201000005882 tinea unguium Diseases 0.000 description 2
- 208000027185 varicose disease Diseases 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- BFUUJUGQJUTPAF-UHFFFAOYSA-N 2-(3-amino-4-propoxybenzoyl)oxyethyl-diethylazanium;chloride Chemical compound [Cl-].CCCOC1=CC=C(C(=O)OCC[NH+](CC)CC)C=C1N BFUUJUGQJUTPAF-UHFFFAOYSA-N 0.000 description 1
- 241000217377 Amblema plicata Species 0.000 description 1
- 206010048768 Dermatosis Diseases 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 239000012080 ambient air Substances 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 238000007373 indentation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229940071648 metered dose inhaler Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000820 nonprescription drug Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960000551 sulfacetamide sodium Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 229960002372 tetracaine Drugs 0.000 description 1
- GKCBAIGFKIBETG-UHFFFAOYSA-N tetracaine Chemical compound CCCCNC1=CC=C(C(=O)OCCN(C)C)C=C1 GKCBAIGFKIBETG-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0037—Containers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/0005—Components or details
- B05B11/0037—Containers
- B05B11/0038—Inner container disposed in an outer shell or outer casing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/1059—Means for locking a pump or its actuation means in a fixed position
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05B—SPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
- B05B11/00—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use
- B05B11/01—Single-unit hand-held apparatus in which flow of contents is produced by the muscular force of the operator at the moment of use characterised by the means producing the flow
- B05B11/10—Pump arrangements for transferring the contents from the container to a pump chamber by a sucking effect and forcing the contents out through the dispensing nozzle
- B05B11/1042—Components or details
- B05B11/108—Means for counting the number of dispensing strokes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B05—SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05C—APPARATUS FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
- B05C17/00—Hand tools or apparatus using hand held tools, for applying liquids or other fluent materials to, for spreading applied liquids or other fluent materials on, or for partially removing applied liquids or other fluent materials from, surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M2039/226—Spindles or actuating means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/10—General characteristics of the apparatus with powered movement mechanisms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/27—General characteristics of the apparatus preventing use
- A61M2205/276—General characteristics of the apparatus preventing use preventing unwanted use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/581—Means for facilitating use, e.g. by people with impaired vision by audible feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
- A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/04—Skin
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mechanical Engineering (AREA)
- Tropical Medicine & Parasitology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Cardiology (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Medicinal Preparation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epidemiology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462057064P | 2014-09-29 | 2014-09-29 | |
| US201562108344P | 2015-01-27 | 2015-01-27 | |
| PCT/US2015/053030 WO2016054104A1 (en) | 2014-09-29 | 2015-09-29 | Device and method for dispensing a drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2847599T3 true ES2847599T3 (es) | 2021-08-03 |
Family
ID=54293384
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES15779121T Active ES2847599T3 (es) | 2014-09-29 | 2015-09-29 | Dispositivo para dispensar un fármaco |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US9440056B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3200863B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6684272B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR101923331B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN107106826B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2015323863B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2962947C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2847599T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL251395B (cg-RX-API-DMAC7.html) |
| MX (1) | MX381830B (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ731349A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11201702485SA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2016054104A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201701970B (cg-RX-API-DMAC7.html) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10421089B2 (en) * | 2015-12-25 | 2019-09-24 | Yoshino Kogyosho Co., Ltd. | Discharge container for discharging contents onto discharge surface |
| US9763509B1 (en) * | 2016-06-17 | 2017-09-19 | Avon Products, Inc. | Applicator for personal care |
| SG11201901147TA (en) * | 2016-08-25 | 2019-03-28 | Validose Inc | System and method for controlled medical therapy |
| JP6910142B2 (ja) * | 2016-12-28 | 2021-07-28 | 株式会社吉野工業所 | 造形面に内容物を吐出する吐出容器 |
| US10682506B2 (en) * | 2017-04-12 | 2020-06-16 | Koyo Sangyo Co., Ltd. | Connecting structure for medical use |
| USD833294S1 (en) * | 2017-07-12 | 2018-11-13 | Perkin & Perkin LLC | Portable spray bottle |
| CN108175686B (zh) * | 2017-12-18 | 2023-10-27 | 上海本神健康科技有限公司 | 多功能红外艾灸拔罐仪及罐具 |
| FR3077496B1 (fr) * | 2018-02-06 | 2024-03-15 | Nemera La Verpilliere | Dispositif d’assistance a l’utilisation d’un dispositif de distribution a activation axiale |
| FR3079430A1 (fr) * | 2018-03-29 | 2019-10-04 | Primequal Sa | Dispositif et embout d'application et d'etalement d'un produit de type liquide, gel ou pate |
| WO2019217926A1 (en) * | 2018-05-11 | 2019-11-14 | Brickell Biotech, Inc. | Applicator and system for pharmaceutical preparation and method of use |
| CN109224279A (zh) * | 2018-10-24 | 2019-01-18 | 秦金凤 | 一种股藓涂药膏器 |
| DE202019103061U1 (de) * | 2019-05-29 | 2020-09-01 | Louvrette Gmbh Design X Packaging | Vorrichtung zur Aufbewahrung und Abgabe einer flüssigen oder pastösen Masse |
| CN110433391B (zh) * | 2019-08-16 | 2023-01-13 | 杭州市红十字会医院 | 一种呼吸科用挤压式喷药装置 |
| JP7527556B2 (ja) * | 2019-09-10 | 2024-08-05 | 大成化工株式会社 | 計量機構、及びそれを備えた定量吐出容器並びに定量塗布具 |
| KR102391865B1 (ko) | 2020-04-03 | 2022-04-27 | 재단법인대구경북과학기술원 | 약물 전달 디바이스 |
| CN112843456A (zh) * | 2021-02-04 | 2021-05-28 | 王艳 | 一种内科临床用四肢敷药器 |
| GB2605643B (en) * | 2021-04-09 | 2026-02-25 | Wype Ltd | Dispenser |
| EP4323049B1 (en) * | 2021-04-15 | 2025-05-28 | Xero Pharmaceuticals IP B.V. | Underarm spray delivery device |
| WO2022226407A1 (en) * | 2021-04-24 | 2022-10-27 | Pneuma Respiratory, Inc. | Respiratory droplet delivery device with face seal and methods of use |
| US12702220B2 (en) * | 2021-10-05 | 2026-08-11 | Alexander Weber | Self-dispensing low volume applicator |
| GB2617328A (en) * | 2022-03-31 | 2023-10-11 | Consort Medical Ltd | Fluid delivery device |
| CN114849049B (zh) * | 2022-05-10 | 2023-11-10 | 贵州省人民医院 | 一种小儿膝盖创伤消毒装置 |
| CN115284542A (zh) * | 2022-05-30 | 2022-11-04 | 中国重汽集团济南动力有限公司 | 一种汽车制造用模具 |
| CN115363862B (zh) * | 2022-10-25 | 2022-12-27 | 吉林大学 | 用于清创伤口的伤口敷料护理装置 |
| US12070415B1 (en) | 2023-12-11 | 2024-08-27 | John Z. Blazevich | Eye drop dispenser |
| US12403035B1 (en) * | 2024-05-03 | 2025-09-02 | John Z. Blazevich | Eye drop dispenser |
| WO2026007166A1 (zh) * | 2024-07-03 | 2026-01-08 | 苏州新劢德医疗器械科技有限公司 | 用于雾化器的触发组件和雾化器 |
| USD1093605S1 (en) | 2024-08-22 | 2025-09-16 | John Z. Blazevich | Eye drop dispenser |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US502590A (en) | 1893-08-01 | Window-garden spray | ||
| US2961679A (en) | 1958-08-27 | 1960-11-29 | Glenn F Claypool | Combination container and applicator for cosmetics and the like |
| GB890348A (en) | 1959-07-06 | 1962-02-28 | Hedley Thomas & Co Ltd | Improvements in liquid applicators |
| US3655952A (en) | 1971-03-15 | 1972-04-11 | Portion Trol Liquor Systems In | Liquid dispenser counting mechanism |
| US4402427A (en) | 1981-07-22 | 1983-09-06 | The Procter & Gamble Company | Cartridge piston with integrally molded sealing plug |
| US4445626A (en) | 1982-02-10 | 1984-05-01 | The Purdue Frederick Company | Metering device for dispensing selected amounts of viscous material |
| DE3208436C2 (de) | 1982-02-22 | 1985-09-26 | Glasgerätebau Hirschmann, 7101 Eberstadt | Flaschendispenser |
| DE3302160A1 (de) * | 1983-01-22 | 1984-07-26 | Ing. Erich Pfeiffer GmbH & Co KG, 7760 Radolfzell | Betaetigbare dosiereinrichtung |
| DE4021263C2 (de) | 1990-07-04 | 1996-04-11 | Pfeiffer Erich Gmbh & Co Kg | Austragvorrichtung für Medien |
| AU2733195A (en) * | 1994-06-15 | 1996-01-05 | Novo Nordisk A/S | A device for storing and applying a viscous substance |
| DE19549033C1 (de) * | 1995-12-28 | 1997-05-28 | Boehringer Ingelheim Int | Mechanisches Zählwerk für ein Dosiergerät |
| US6164498A (en) | 1999-09-01 | 2000-12-26 | Mcneil-Ppc. Inc. | Pump dispenser |
| DE10159692A1 (de) | 2001-11-29 | 2003-06-12 | Pfeiffer Erich Gmbh & Co Kg | Dosiervorrichtung |
| AU2002953483A0 (en) * | 2002-12-20 | 2003-01-09 | Acrux Dds Pty. Ltd. | Usage indicator |
| US20040127861A1 (en) * | 2002-12-26 | 2004-07-01 | Bradley Pharmaceuticals, Inc. | Method and apparatus for dispensing a composition |
| US6758620B1 (en) | 2003-08-13 | 2004-07-06 | Valley Design, Inc. | Metered dose dispenser dabber device |
| ITMI20030584U1 (it) | 2003-12-12 | 2005-06-13 | Intercos Italiana | Disposiotivo applicatore di prodotti cosmetici |
| GB0405397D0 (en) * | 2004-03-10 | 2004-04-21 | Glaxo Group Ltd | An inhaler |
| US7886934B2 (en) * | 2005-01-20 | 2011-02-15 | Trudell Medical International | Dispensing device |
| US8215861B2 (en) | 2006-02-15 | 2012-07-10 | L'oreal | Packaging and applicator device |
| US7871217B2 (en) | 2006-12-12 | 2011-01-18 | The Clorox Company | Pump systems for pump dispensers |
| CA2673479A1 (en) | 2006-12-22 | 2008-07-03 | Schering Corporation | Dispenser dose counter mechanism |
| US8267610B2 (en) | 2007-07-30 | 2012-09-18 | Avery Goodman | Apparatus for storing and hygenically dispensing a cleansing solution |
| DE102007045438B4 (de) * | 2007-09-22 | 2016-09-01 | Boehringer Ingelheim International Gmbh | Inhalier-Gerät |
| WO2009086009A1 (en) * | 2007-12-21 | 2009-07-09 | Schering Corporation | Dose counters and containers |
| US20140323993A1 (en) * | 2011-03-25 | 2014-10-30 | Leo Pharma A/S | Applicator |
| CN103974743A (zh) | 2011-10-21 | 2014-08-06 | 利奥制药公司 | 分配系统 |
| US8814005B2 (en) | 2012-04-27 | 2014-08-26 | Pibed Limited | Foam dispenser |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| EP2983742B1 (en) | 2013-04-10 | 2019-06-12 | Sanofi | Hand-held drug injection device and dose setting limiter mechanism therefor |
| JP2016518900A (ja) | 2013-04-10 | 2016-06-30 | サノフイ | 薬物送達デバイスの駆動機構 |
-
2015
- 2015-09-29 AU AU2015323863A patent/AU2015323863B2/en active Active
- 2015-09-29 CN CN201580064668.5A patent/CN107106826B/zh active Active
- 2015-09-29 CA CA2962947A patent/CA2962947C/en active Active
- 2015-09-29 JP JP2017515914A patent/JP6684272B2/ja active Active
- 2015-09-29 WO PCT/US2015/053030 patent/WO2016054104A1/en not_active Ceased
- 2015-09-29 NZ NZ731349A patent/NZ731349A/en unknown
- 2015-09-29 KR KR1020177008899A patent/KR101923331B1/ko active Active
- 2015-09-29 ES ES15779121T patent/ES2847599T3/es active Active
- 2015-09-29 EP EP15779121.1A patent/EP3200863B1/en active Active
- 2015-09-29 MX MX2017004053A patent/MX381830B/es unknown
- 2015-09-29 US US14/869,799 patent/US9440056B2/en active Active
- 2015-09-29 SG SG11201702485SA patent/SG11201702485SA/en unknown
-
2016
- 2016-05-04 US US15/146,627 patent/US10092736B2/en active Active
-
2017
- 2017-03-22 ZA ZA2017/01970A patent/ZA201701970B/en unknown
- 2017-03-27 IL IL251395A patent/IL251395B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| WO2016054104A1 (en) | 2016-04-07 |
| EP3200863A1 (en) | 2017-08-09 |
| SG11201702485SA (en) | 2017-04-27 |
| CN107106826A (zh) | 2017-08-29 |
| US20160243345A1 (en) | 2016-08-25 |
| US9440056B2 (en) | 2016-09-13 |
| IL251395B (en) | 2020-08-31 |
| AU2015323863B2 (en) | 2020-07-02 |
| ZA201701970B (en) | 2019-08-28 |
| CA2962947C (en) | 2021-02-23 |
| JP6684272B2 (ja) | 2020-04-22 |
| US20160089526A1 (en) | 2016-03-31 |
| CA2962947A1 (en) | 2016-04-07 |
| MX381830B (es) | 2025-03-13 |
| NZ731349A (en) | 2022-07-01 |
| KR20170048519A (ko) | 2017-05-08 |
| MX2017004053A (es) | 2017-07-07 |
| KR101923331B1 (ko) | 2018-11-28 |
| JP2017534331A (ja) | 2017-11-24 |
| AU2015323863A1 (en) | 2017-05-18 |
| US10092736B2 (en) | 2018-10-09 |
| EP3200863B1 (en) | 2020-11-04 |
| IL251395A0 (en) | 2017-05-29 |
| CN107106826B (zh) | 2020-10-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3200863B1 (en) | Device for dispensing a drug | |
| JP2017534331A5 (cg-RX-API-DMAC7.html) | ||
| ES2442017T3 (es) | Sistema de dispensador de dosis medidas con botón pulsador | |
| ES2354016T3 (es) | Dispositivo de administración. | |
| US9867933B2 (en) | Delivery system for dispensing metered volumes of pure or sterile flowable substances | |
| JP6067672B2 (ja) | アプリケータ | |
| JP2011502656A (ja) | 定量ジェルディスペンサ | |
| JP5339650B2 (ja) | 物質を基質上に送達するバイアル | |
| TW201946667A (zh) | 塗佈用具及其施用系統 | |
| US11247022B2 (en) | Devices and methods for delivering fluid to a nasal cavity | |
| ES2964101T3 (es) | Dispositivo de inhalación mejorado | |
| WO2009086009A1 (en) | Dose counters and containers | |
| WO2017011361A1 (en) | Collapsible liquid irrigation container | |
| WO2020003149A1 (en) | A dispenser for a single drop administration of liquid for a pharmaceutical application, being registered as medicine or being a medical product, especially of an ophthalmic liquid, a dispensing set, and use thereof | |
| CA2606469A1 (en) | Apparatus and method for administering ophthalmic solutions | |
| NZ622265B2 (en) | Dispensing systems |